Company Filing History:
Years Active: 2022-2024
Title: David Conant: Innovator in Nucleic Acid Analysis
Introduction
David Conant is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the analysis of nucleic acid sequences. With a total of four patents to his name, Conant's work has advanced the understanding and application of genetic research.
Latest Patents
Conant's latest patents include innovative methods for analyzing nucleic acid sequences. One of his notable inventions provides a method for determining a base trace by trimming a Sanger sequencing trace of a plurality of nucleic acid molecules from a sample. This method is based on first and second target sequences, which can be found in the nucleic acid molecules or their complements. Another significant patent focuses on the design and use of guide RNAs for hybridizing genomic regions of interest. This invention outlines methods for editing genomic regions using sets of guide RNAs, showcasing Conant's expertise in genetic engineering.
Career Highlights
David Conant is currently employed at Synthego Corporation, a company known for its advancements in genome engineering. His work at Synthego has allowed him to collaborate with leading experts in the field, further enhancing his contributions to biotechnology.
Collaborations
Conant has worked alongside talented colleagues such as Richard Stoner and Travis Maures. Their collaborative efforts have fostered an environment of innovation and creativity, leading to groundbreaking advancements in genetic research.
Conclusion
David Conant's contributions to the field of biotechnology, particularly in nucleic acid analysis, have established him as a key figure in the industry. His innovative patents and collaborative spirit continue to drive advancements in genetic research.